Neuropsychological Features of Asymptomatic c.709-1G>A Progranulin Mutation Carriers

被引:20
|
作者
Barandiaran, Myriam [1 ,2 ,3 ]
Estanga, Ainara [2 ,3 ,4 ]
Moreno, Fermin [1 ,2 ,3 ,4 ]
Indakoetxea, Begona [1 ,2 ,3 ,4 ]
Alzualde, Ainhoa [2 ,3 ,4 ]
Balluerka, Nekane [5 ]
Marti Masso, Jose Felix [1 ,2 ,3 ,4 ]
Lopez de Munain, Adolfo [1 ,2 ,3 ,4 ]
机构
[1] Hosp Donostia, Dept Neurol, San Sebastian 20014, Gipuzkoa, Spain
[2] Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Area 6, Gipuzkoa, Spain
[3] Ilundain Fundazioa, Neurogenet Res Unit, Gipuzkoa, Spain
[4] Inst Biodonostia, Neurociences Area, San Sebastian, Gipuzkoa, Spain
[5] Univ Basque Country, Dept Social Psychol & Methodol Behav Sci, San Sebastian, Spain
关键词
Frontotemporal dementia; Cognition; Executive function; Attention; Primary progressive aphasia; Early diagnosis; FRONTOTEMPORAL DEMENTIA; GENE;
D O I
10.1017/S1355617712000823
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the progranulin (PGRN) gene have been identified as a cause of frontotemporal dementia (FTD). However, little is known about the neuropsychological abilities of asymptomatic carriers of these mutations. The aim of the study was to assess cognitive functioning in asymptomatic c.709-1G>A PGRN mutation carriers. We hypothesized that poorer neuropsychological performance could be present before the development of clinically significant FTD symptoms. Thirty-two asymptomatic first-degree relatives of FTD patients carrying the c.709-1G>A mutation served as study participants, including 13 PGRN mutation carriers (A-PGRN+) and 19 non-carriers (PGRN-). A neuropsychological battery was administered. We found that the A-PGRN+ participants obtained significantly poorer scores than PGRN- individuals on tests of attention (Trail-Making Test Part A), mental flexibility (Trail-Making Test Part B), and language (Boston Naming Test). Poorer performance on these tests in asymptomatic PGRN mutation carriers may reflect a prodromal phase preceding the onset of clinically significant symptoms of FTD. (JINS, 2012, 18, 1086-1090)
引用
收藏
页码:1086 / 1090
页数:5
相关论文
共 50 条
  • [41] The RYR1 g.1843C>T mutation is associated with the effect of the IGF2 intron3-g.3072G>A mutation on muscle hypertrophy
    Stinckens, A.
    Van den Maagdenberg, K.
    Luyten, T.
    Georges, M.
    De Smet, S.
    Buys, N.
    ANIMAL GENETICS, 2007, 38 (01) : 67 - 71
  • [42] Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation
    Baert, Annelot
    Depuydt, Julie
    Van Maerken, Tom
    Poppe, Bruce
    Malfait, Fransiska
    Storm, Katrien
    van den Ende, Jenneke
    Van Damme, Tim
    De Nobele, Sylvia
    Perletti, Gianpaolo
    De Leeneer, Kim
    Claes, Kathleen B. M.
    Vral, Anne
    BREAST CANCER RESEARCH, 2016, 18
  • [43] Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation
    Annelot Baert
    Julie Depuydt
    Tom Van Maerken
    Bruce Poppe
    Fransiska Malfait
    Katrien Storm
    Jenneke van den Ende
    Tim Van Damme
    Sylvia De Nobele
    Gianpaolo Perletti
    Kim De Leeneer
    Kathleen B. M. Claes
    Anne Vral
    Breast Cancer Research, 18
  • [44] Evolution from the asymptomatic to symptomatic state in familial FTD: longitudinal neuropsychological and MRI findings in three MAPT mutation carriers
    Dheel, C.
    Przybelski, S.
    Senjem, M.
    Kantarci, K.
    Jones, D.
    Fields, J.
    Machulda, M.
    Jack, C., Jr.
    Rademakers, R.
    Knopman, D.
    Wszolek, Z.
    Petersen, R.
    Boeve, B.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 403 - 403
  • [45] A prevalent pathogenic GAMT mutation (c.59G>C) in Portugal
    Almeida, L. S.
    Vilarinho, L.
    Darmin, P. S.
    Rosenberg, E. H.
    Martinez-Munoz, C.
    Jakobs, C.
    Salomons, G. S.
    MOLECULAR GENETICS AND METABOLISM, 2007, 91 (01) : 1 - 6
  • [46] IN VITRO CHARACTERIZATION OF THE α-THALASSEMIA POINT MUTATION HBA2:c.95+1G>A [IVS-I-1(G>A) (α2)]
    Qadah, Talal
    Finlayson, Jill
    Ghassemifar, Reza
    HEMOGLOBIN, 2012, 36 (01) : 38 - 46
  • [47] Disease progression in STGD1 patients with c.768G>T mutation
    Li, Catherina H. Z.
    Dhooge, Patty P. A.
    Pas, Jeroen
    Collin, Rob W. J.
    Hoyng, Carel C. B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [48] The first titin (c.59926+1G > A) founder mutation associated with dilated cardiomyopathy
    Hoorntje, Edgar T.
    van Spaendonck-Zwarts, Karin Y.
    Rijdt, Wouter P. te
    Boven, Ludolf
    Vink, Aryan
    van der Smagt, Jasper J.
    Asselbergs, FolkertW.
    van Wijngaarden, Jan
    Hennekam, Eric A.
    Pinto, Yigal M.
    Deprez, Ronald H. Lekanne
    Barge-Schaapveld, Daniela Q. C. M.
    Bootsma, Marianne
    Regieli, Jakub
    Hoedemaekers, Yvonne M.
    Jongbloed, Jan D. H.
    van den Berg, Maarten P.
    van Tintelen, J. Peter
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (04) : 803 - +
  • [50] Incomplete penetrance of GLMN gene c.395-1G>C mutation in a family with glomuvenous malformations
    Borroni, Riccardo G.
    Grassi, Sara
    Diegoli, Marta
    Grasso, Maurizia
    Arbustini, Eloisa
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (11) : 1362 - 1364